|
Volumn 2, Issue 1, 2007, Pages 91-94
|
Tissue engineering today, not tomorrow
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFLAMMATORY AGENT;
BIOMATERIAL;
BISPHOSPHONIC ACID DERIVATIVE;
BONE MORPHOGENETIC PROTEIN;
COLLAGEN;
FIBRIN;
FIBRINOGEN;
FIBROBLAST GROWTH FACTOR 2;
GAMMA INTERFERON;
IODINE 125;
MACROGOL;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
NANOFIBER;
POLYCAPROLACTONE;
POLYETHYLENE TEREPHTHALATE;
POLYGLACTIN;
POLYGLYCOLIC ACID;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR ALPHA;
ALLOGENEIC STEM CELL TRANSPLANTATION;
ALLOGRAFT;
AMNION;
ANGIOGENESIS;
BIOREACTOR;
BONE REGENERATION;
CELL DIFFERENTIATION;
CELL ISOLATION;
CELL SURVIVAL;
CELL TRANSPLANTATION;
CONFERENCE PAPER;
CORNEA EPITHELIUM;
DUCHENNE MUSCULAR DYSTROPHY;
EMBRYONIC STEM CELL;
GENE EXPRESSION;
GRAFT REJECTION;
GRAFT VERSUS HOST REACTION;
HEART MUSCLE CELL;
HUMAN;
IMMUNE RESPONSE;
IMMUNOLOGICAL TOLERANCE;
IMMUNOMODULATION;
LIMBAL STEM CELL TRANSPLANTATION;
MESENCHYMAL STEM CELL;
MUSCLE REGENERATION;
NONHUMAN;
OSTEOPOROSIS;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PHENOTYPE;
PRIORITY JOURNAL;
TISSUE ENGINEERING;
BIOLOGICAL MARKERS;
GENE THERAPY;
GREAT BRITAIN;
HUMANS;
MESENCHYMAL STEM CELLS;
NANOTECHNOLOGY;
REGENERATIVE MEDICINE;
TISSUE ENGINEERING;
|
EID: 34249662635
PISSN: 17460751
EISSN: None
Source Type: Journal
DOI: 10.2217/17460751.2.1.91 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|